The Real Reason Your Doctor Won't Tell You to Stop Your PPI

Proton pump inhibitors are among the most prescribed drugs in America. Roughly 15 million people swallow one every day—Prilosec, Nexium, Prevacid, Protonix—to shut down the acid pumps in their stomachs. For two weeks, they're a miracle. For a decade, we're running a nationwide experiment on ourselves, and the results are coming in. Here's the uncomfortable part: the people who profit from that experiment are not the people taking the pill. Start with the science. PPIs work by blocking the enzymes that produce stomach acid. That's great if you have an ulcer or real GERD. But a huge share of prescriptions aren't for those things. They're for "a little heartburn," or they started in a hospital and simply never stopped. One well-known study found that up to 70 percent of PPI prescriptions lack a clear ongoing indication. Translation: millions of people are taking a powerful drug for a problem they may no longer have. The risks aren't imaginary. Long-term use has been linked to fractures, kidney inflammation, low magnesium, B12 deficiency, and a nasty increase in C. diff infections. The FDA has slapped warnings on the labels. None of this means PPIs are poison—for the right patient, they're genuinely life-changing. But "linked to" is doing careful work in that sentence. Some of these associations may reflect the fact that sicker people take more drugs, not that the drug made them sick. That caveat is real, and the internet routinely ignores it. So why does the prescription pad stay busy? Follow the money. Brand-name PPIs were blockbusters—Nexium alone pulled in billions annually at its peak. Even now, with cheap generics, there's a machine behind the scenes: pharmacy middlemen who profit from volume, hospital protocols that default to starting a PPI, and a health care system that pays far better for a pill than for a 20-minute conversation about diet, alcohol, and late-night eating. Nobody gets rich teaching you to raise the head of your bed. There's also a quieter force: inertia. Deprescribing takes time. It can cause rebound acid—a brutal few weeks where symptoms flare because your stomach overcorrects. That rebound convinces patients the drug is essential and convinces doctors it's easier to just refill. The pill doesn't just treat the problem. It manufactures its own demand. And here's the twist the wellness crowd won't tell you: quitting cold turkey on your own is a bad idea. If you've been on a PPI for years, stopping abruptly can trigger exactly the misery you fear—and in rare cases, masking a serious condition. Tapering under medical supervision is the move. So is asking your doctor a simple, uncomfortable question: "Do I still need this, and how would we know?" That question is free. It's also the one thing nobody in the supply chain is paid to ask you. The honest takeaway is boring but true: PPIs are neither the miracle nor the villain the loudest voices claim. They're a tool that got handed out like candy and now needs a cleanup. The real scandal isn't the drug. It's how little anyone profits from helping you stop it. If your doctor put you on a PPI and never set an end date, that's not a treatment plan—that's a subscription. Ask for the exit strategy.